Clin2
NCT07299500Likely a fitRecruiting

Toxoplasmosis study in non-HIV immune compromised patients

Cerebral Toxoplasmosis

Part of Brain & nervous system, Immune system & allergy, Infections clinical trials.

This study looks at toxoplasmosis infections in people with weakened immune systems (not caused by HIV). It aims to learn more about how these infections happen and how they affect patients.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older
  • You have a weakened immune system (for example from an organ transplant, cancer treatment, an autoimmune disease, or certain medications)
  • You have had at least one positive toxoplasmosis PCR test (a test that finds the infection's genetic material)
  • You do not have HIV
  • Your toxoplasmosis was not present at birth (congenital)
  • If you have toxoplasmosis only in your eye, you must have a weakened immune system to be included

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07054918Not yet recruiting
Isolated positive toxoplasma blood test without symptoms

This study looks at people who have a positive toxoplasma blood test (PCR) but no symptoms. It aims to learn more about what this finding means and how it should be treated.

Clermont-Ferrand
NCT06305468Recruiting
Toxoplasmosis prognosis in ICU patients diagnosed by PCR

This study looks at how people with severe toxoplasmosis (a parasitic infection) that affects the brain or spreads in the body, and who need intensive care, recover. It uses a sensitive test called PCR to confirm the infection.

Paris, France
NCT04474132Recruiting
Testing for current or past Toxoplasmosis infection

This study checks whether a simple “point-of-care” test can detect current or past Toxoplasmosis infection (a common germ). Your results may help evaluate how well the test works and how it could be used in care.

Chicago, Illinois
NCT00004317Recruiting· Phase 4
Treating Congenital Toxoplasmosis With Three Medications

This study tests a combination of three medications (pyrimethamine, sulfadiazine, and leucovorin) to treat toxoplasmosis—a parasitic infection passed from mother to baby during pregnancy. The goal is to see if early treatment prevents serious complications in infected infants.

Chicago, Illinois
NCT06980298Not yet recruiting
Toxoplasma infection in children with epilepsy or ADHD

This study checks whether children with epilepsy or ADHD have a higher chance of having a past infection from a parasite called toxoplasma. A simple blood test can show if your child has been exposed, which might help understand possible links to these conditions.

Sohag
NCT07346833Recruiting
MicroRNA in women with toxoplasmosis and mental illness

This study looks at tiny molecules in the blood (called microRNAs) that might help doctors tell the difference between mental health conditions in women who have had a past infection with the parasite Toxoplasma. The goal is to find better ways to diagnose and treat these conditions.

Banhā, El Qalyoubia

Hear when a new Cerebral Toxoplasmosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.